These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
445 related articles for article (PubMed ID: 8205533)
1. Colocalized alterations in connexin32 and cytochrome P450IIB1/2 by phenobarbital and related liver tumor promoters. Neveu MJ; Babcock KL; Hertzberg EL; Paul DL; Nicholson BJ; Pitot HC Cancer Res; 1994 Jun; 54(12):3145-52. PubMed ID: 8205533 [TBL] [Abstract][Full Text] [Related]
2. Multiple mechanisms are responsible for altered expression of gap junction genes during oncogenesis in rat liver. Neveu MJ; Hully JR; Babcock KL; Hertzberg EL; Nicholson BJ; Paul DL; Pitot HC J Cell Sci; 1994 Jan; 107 ( Pt 1)():83-95. PubMed ID: 8175925 [TBL] [Abstract][Full Text] [Related]
3. P-450 enzyme induction by 5-ethyl-5-phenylhydantoin and 5,5-diethylhydantoin, analogues of barbiturate tumor promoters phenobarbital and barbital, and promotion of liver and thyroid carcinogenesis initiated by N-nitrosodiethylamine in rats. Diwan BA; Rice JM; Nims RW; Lubet RA; Hu H; Ward JM Cancer Res; 1988 May; 48(9):2492-7. PubMed ID: 3356011 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of rat liver gap junction intercellular communication by tumor-promoting agents in vivo. Association with aberrant localization of connexin proteins. Krutovskikh VA; Mesnil M; Mazzoleni G; Yamasaki H Lab Invest; 1995 May; 72(5):571-7. PubMed ID: 7745951 [TBL] [Abstract][Full Text] [Related]
5. Proliferation-associated differences in the spatial and temporal expression of gap junction genes in rat liver. Neveu MJ; Hully JR; Babcock KL; Vaughan J; Hertzberg EL; Nicholson BJ; Paul DL; Pitot HC Hepatology; 1995 Jul; 22(1):202-12. PubMed ID: 7601414 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of gap junctional intercellular communication by tumor promoters in connexin43 and connexin32-expressing liver cells: cell specificity and role of protein kinase C. Ren P; Mehta PP; Ruch RJ Carcinogenesis; 1998 Jan; 19(1):169-75. PubMed ID: 9472709 [TBL] [Abstract][Full Text] [Related]
7. EGF receptors of hepatocytes from rats treated with phenobarbital are sensitized to down-regulation by phenobarbital in culture. Dalton SR; Jirtle RL; Meyer SA Toxicol Appl Pharmacol; 2000 Jun; 165(2):115-26. PubMed ID: 10828207 [TBL] [Abstract][Full Text] [Related]
8. Identification of cytochrome P-450IIB1 as a cocaine-bioactivating isoform in rat hepatic microsomes and in cultured rat hepatocytes. Boelsterli UA; Lanzotti A; Göldlin C; Oertle M Drug Metab Dispos; 1992; 20(1):96-101. PubMed ID: 1347004 [TBL] [Abstract][Full Text] [Related]
9. Phenobarbital induction of CYP2B1/2 in primary hepatocytes: endocrine regulation and evidence for a single pathway for multiple inducers. Ganem LG; Trottier E; Anderson A; Jefcoate CR Toxicol Appl Pharmacol; 1999 Feb; 155(1):32-42. PubMed ID: 10036216 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of gap junctional intercellular communication by barbiturates in long-term primary cultured rat hepatocytes is correlated with liver tumour promoting activity. Ren P; Ruch RJ Carcinogenesis; 1996 Oct; 17(10):2119-24. PubMed ID: 8895477 [TBL] [Abstract][Full Text] [Related]
12. Low dose DDT inhibition of hepatocarcinogenesis initiated by diethylnitrosamine in male rats: possible mechanisms. Kushida M; Sukata T; Uwagawa S; Ozaki K; Kinoshita A; Wanibuchi H; Morimura K; Okuno Y; Fukushima S Toxicol Appl Pharmacol; 2005 Nov; 208(3):285-94. PubMed ID: 15885732 [TBL] [Abstract][Full Text] [Related]
13. Phenobarbital induction of hepatic CYP2B1 and CYP2B2: pretranscriptional and post-transcriptional effects of gender, adult age, and phenobarbital dose. Agrawal AK; Shapiro BH Mol Pharmacol; 1996 Mar; 49(3):523-31. PubMed ID: 8643092 [TBL] [Abstract][Full Text] [Related]
14. WY-14,643-mediated promotion of hepatocarcinogenesis in connexin32-wild-type and connexin32-null mice. Moennikes O; Stahl S; Bannasch P; Buchmann A; Schwarz M Carcinogenesis; 2003 Sep; 24(9):1561-5. PubMed ID: 12819187 [TBL] [Abstract][Full Text] [Related]
15. Lack of phenobarbital-mediated promotion of hepatocarcinogenesis in connexin32-null mice. Moennikes O; Buchmann A; Romualdi A; Ott T; Werringloer J; Willecke K; Schwarz M Cancer Res; 2000 Sep; 60(18):5087-91. PubMed ID: 11016633 [TBL] [Abstract][Full Text] [Related]
16. Comparative effects of carbamazepine and carbamazepine-10,11-epoxide on hepatic cytochromes P450 in the rat. Panesar SK; Bandiera SM; Abbott FS Drug Metab Dispos; 1996 Jun; 24(6):619-27. PubMed ID: 8781776 [TBL] [Abstract][Full Text] [Related]
17. Regulation of phenobarbital-inducible cytochrome P450 2B1/2 mRNA by lovastatin and oxysterols in primary cultures of adult rat hepatocytes. Kocarek TA; Schuetz EG; Guzelian PS Toxicol Appl Pharmacol; 1993 Jun; 120(2):298-307. PubMed ID: 8511800 [TBL] [Abstract][Full Text] [Related]
18. Transgenic disruption of gap junctional intercellular communication enhances early but not late stage hepatocarcinogenesis in the rat. Hokaiwado N; Asamoto M; Ogawa K; Shirai T Toxicol Pathol; 2005; 33(6):695-701. PubMed ID: 16243774 [TBL] [Abstract][Full Text] [Related]
19. Activities of benzphetamine N-demethylase and aryl hydrocarbon hydroxylase in cells isolated from gamma-glutamyl transpeptidase-positive foci and surrounding liver. Hanigan MH; Pitot HC J Natl Cancer Inst; 1985 Dec; 75(6):1107-12. PubMed ID: 2866268 [TBL] [Abstract][Full Text] [Related]
20. Critical role of extracellular matrix on induction by phenobarbital of cytochrome P450 2B1/2 in primary cultures of adult rat hepatocytes. Brown SE; Guzelian CP; Schuetz E; Quattrochi LC; Kleinman HK; Guzelian PS Lab Invest; 1995 Dec; 73(6):818-27. PubMed ID: 8558843 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]